1. Home
  2. TARS vs MANU Comparison

TARS vs MANU Comparison

Compare TARS & MANU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$68.26

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Logo Manchester United Ltd.

MANU

Manchester United Ltd.

HOLD

Current Price

$20.65

Market Cap

3.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TARS
MANU
Founded
2016
1878
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.6B
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
TARS
MANU
Price
$68.26
$20.65
Analyst Decision
Strong Buy
Buy
Analyst Count
10
2
Target Price
★ $99.80
$22.96
AVG Volume (30 Days)
★ 652.8K
335.1K
Earning Date
11-03-2026
12-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 48.21
N/A
EPS
N/A
★ N/A
Revenue
★ $451,360,000.00
N/A
Revenue This Year
$61.17
$11.71
Revenue Next Year
$26.47
$6.21
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 146.71
N/A
52 Week Low
$53.89
$14.85
52 Week High
$91.53
$24.45

Technical Indicators

Market Signals
Indicator
TARS
MANU
Relative Strength Index (RSI) 39.23 48.78
Support Level $60.95 $20.12
Resistance Level $74.51 $21.17
Average True Range (ATR) 3.34 0.46
MACD -0.37 0.07
Stochastic Oscillator 2.22 54.77

Price Performance

Historical Comparison
TARS
MANU

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

About MANU Manchester United Ltd.

Manchester United PLC operates as a professional football club with related activities, generating revenue prominently through commercial, broadcasting, and matchday segments. The commercial segment monetizes the various brands via sponsorships, retail, merchandising, apparel, and product licensing. Broadcasting revenue comes from television rights linked to football leagues and competitions, alongside content delivered through its dedicated TV channel all over the globe. Matchday income includes ticket sales, hospitality, merchandise, and services at its stadium. Manchester United is based in England. The company's operations and fan base extend to many countries, supporting a diversified revenue model based on brand engagement and football-related content.

Share on Social Networks: